Avinger, Inc.

NasdaqCM:AVGR Voorraadrapport

Marktkapitalisatie: US$1.8m

Avinger Toekomstige groei

Future criteriumcontroles 2/6

Avinger is forecast to grow earnings and revenue by 19.9% and 28.9% per annum respectively while EPS is expected to grow by 60% per annum.

Belangrijke informatie

19.9%

Groei van de winst

60.0%

Groei van de winst per aandeel

Medical Equipment winstgroei17.4%
Inkomstengroei28.9%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt09 Aug 2024

Recente toekomstige groei-updates

Recent updates

Avinger GAAP EPS of -$0.94 beats by $0.15, revenue of $2.13M misses by $0.25M

Aug 11

Is Avinger (NASDAQ:AVGR) Using Debt Sensibly?

Nov 25
Is Avinger (NASDAQ:AVGR) Using Debt Sensibly?

Is Avinger (NASDAQ:AVGR) A Risky Investment?

Jun 30
Is Avinger (NASDAQ:AVGR) A Risky Investment?

Avinger shares fall after Q1 results fail to impress Wall Street

May 07

Does Avinger (NASDAQ:AVGR) Have A Healthy Balance Sheet?

Jan 21
Does Avinger (NASDAQ:AVGR) Have A Healthy Balance Sheet?

Avinger 'Hot Penny Stock to buy' - Robinhood

Jan 08

Winst- en omzetgroeiprognoses

NasdaqCM:AVGR - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202618-11N/AN/A1
12/31/202514-13N/AN/A1
12/31/20247-17N/AN/A1
6/30/20247-15-15-15N/A
3/31/20248-16-15-15N/A
12/31/20238-18-14-14N/A
9/30/20238-19-14-14N/A
6/30/20238-22-14-14N/A
3/31/20238-22-15-15N/A
12/31/20228-27-17-17N/A
9/30/20229-28-18-18N/A
6/30/20229-29-18-18N/A
3/31/20229-27-17-17N/A
12/31/202110-22-16-16N/A
9/30/202110-21-15-15N/A
6/30/202110-21-15-15N/A
3/31/20219-22-15-15N/A
12/31/20209-23-15-15N/A
9/30/20209-23-15-15N/A
6/30/20209-23-16-16N/A
3/31/202010-24-16-16N/A
12/31/20199-23-17-17N/A
9/30/20199-24-17-18N/A
6/30/20198-25-17-17N/A
3/31/20198-26-18-18N/A
12/31/20188-36-18-18N/A
9/30/20188-39-20-20N/A
6/30/20188-43-24-24N/A
3/31/20188-49N/A-28N/A
12/31/201710-49N/A-34N/A
9/30/201713-52N/A-40N/A
6/30/201716-55N/A-44N/A
3/31/201718-55N/A-50N/A
12/31/201619-56N/A-53N/A
9/30/201617-56N/A-54N/A
6/30/201615-56N/A-55N/A
3/31/201613-53N/A-49N/A
12/31/201511-50N/A-41N/A
9/30/201511-44N/A-35N/A
6/30/201511-40N/A-28N/A
3/31/201511-37N/A-24N/A
12/31/201411-32N/A-22N/A
9/30/201412-32N/A-23N/A
6/30/201412-33N/A-27N/A
3/31/201412-37N/A-34N/A
12/31/201313-40N/A-41N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: AVGR is forecast to remain unprofitable over the next 3 years.

Winst versus markt: AVGR is forecast to remain unprofitable over the next 3 years.

Hoge groeiwinsten: AVGR is forecast to remain unprofitable over the next 3 years.

Omzet versus markt: AVGR's revenue (28.9% per year) is forecast to grow faster than the US market (8.9% per year).

Hoge groei-inkomsten: AVGR's revenue (28.9% per year) is forecast to grow faster than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if AVGR's Return on Equity is forecast to be high in 3 years time


Ontdek groeibedrijven